ConvaTec Group logo

ConvaTec Group

CNVVY | OTC
Chart Builder DCF Calculator
$13.18
$0.00 (0.00%)
Nov 2, 2026, 9:32 AM ET · Market open

Company Profile

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.

Key Executives

Name Position
Jonathan Mason Chief Executive Officer & Director
Anne Belcher President & Chief Operating Officer of Global Emerging Markets
Bruno Pinheiro President & Chief Operating Officer of Ostomy Care
Emma Rose EVP & Chief People Officer
Fiona Victoria Ryder Chief Financial Officer & Director
Kjersti Grimsrud Biotechnology President & Chief Operating Officer of Infusion Care
Dave Ubachs Chief Digital & Information Officer
David Shepherd Chief Commercial Officer
Evelyn Douglas EVP and Chief Strategy & Business Development Officer
James Edward Spencer Kerton EVP, General Counsel & Company Secretary
Peter Jarvis Chief Operations Officer
ConvaTec Group
ConvaTec Group logo
Country United Kingdom
IPO Date Jan 26, 2017
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 10,910
CEO Jonathan Peter Mason

Contact Details

20 Eastbourne Terrace London, GL W2 6LG United Kingdom

Stock Details

Ticker Symbol CNVVY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 21244X109
ISIN Number US21244X1090
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.